Author:
Lewis Benjamin C.,Korprasertthaworn Porntipa,Miners John O.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics
Reference46 articles.
1. Epigenomics and interindividual differences in drug response;Ivanov;Clin Pharmacol Ther,2012
2. Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388);Luce;Cancer Chemother Rep,1970
3. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1;Reid;Clin Cancer Res,1999
4. Application of homology modeling to generate CYP1A1 mutants with enhanced activation of the cancer chemotherapeutic prodrug dacarbazine;Lewis;Mol Pharmacol,2011
5. Metabolic gene polymorphism frequencies in control populations;Garte;Cancer Epidemiol Biomarkers Prev,2001
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献